These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1103271)

  • 1. The constipating effect of diphenoxylate (Retardinr) in ulcerative colitis. A double-blind controlled trial.
    Engbaek J; Ersböll J; Faurby V; Binder V; Riis P
    Scand J Gastroenterol; 1975; 10(7):695-8. PubMed ID: 1103271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The constipating effect of diphenoxylate (Retardin) in ulcerative colitis. A double-blind controlled study].
    Engbaek J; Ersboll J; Faurby V; Binder V; Riss P
    Ugeskr Laeger; 1975 Apr; 137(18):985-8. PubMed ID: 1096393
    [No Abstract]   [Full Text] [Related]  

  • 3. Difenoxine (R 15403), the active metabolite of diphenoxylate (R 1132). 5. Clinical comparison of difenoxine and diphenoxylate in volunteers and in patients with chronic diarrhea. Double-blind cross-over assessments.
    Rubens R; Verhaegen H; Brugmans J; Schuermans V
    Arzneimittelforschung; 1972 Mar; 22(3):526-9. PubMed ID: 4556767
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled trial of azathioprine in the management of chronic ulcerative colitis.
    Rosenberg JL; Wall AJ; Levin B; Binder HJ; Kirsner JB
    Gastroenterology; 1975 Jul; 69(1):96-9. PubMed ID: 1097295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea.
    Palmer KR; Corbett CL; Holdsworth CD
    Gastroenterology; 1980 Dec; 79(6):1272-5. PubMed ID: 7002706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Double-blind study on the influence of difenoxin hydrochloride on intestinal passage time in healthy volunteers (author's transl)].
    Thurnherr N; Spring P
    Arzneimittelforschung; 1979; 29(3):559-62. PubMed ID: 582746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effect of diphenoxylate with atropine (Lomotil) in patients with chronic diarrhea and fecal incontinence.
    Harford WV; Krejs GJ; Santa Ana CA; Fordtran JS
    Gastroenterology; 1980 Mar; 78(3):440-3. PubMed ID: 7351282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind crossover comparison of loperamide with diphenoxylate in the symptomatic treatment of chronic diarrhea.
    Pelemans W; Vantrappen F
    Gastroenterology; 1976 Jun; 70(6):1030-4. PubMed ID: 773736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of a daily application of mesalazine (Pentasa) suppository with progressive release, in the treatment of ulcerative proctitis. A double-blind versus placebo randomized trial].
    Ngô Y; Gélinet JM; Ivanovic A; Kac J; Schénowitz G; Vilotte J; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(10):782-6. PubMed ID: 1478406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis.
    Thomas GA; Rhodes J; Ragunath K; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):769-76. PubMed ID: 8864674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of loperamide and diphenoxylate in the treatment of chronic diarrhoea caused by intestinal resection.
    Bergman L; Djärv L
    Ann Clin Res; 1981 Dec; 13(6):402-5. PubMed ID: 6753707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
    Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
    Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 6: Clinical pharmacology. Placebo-controlled comparison of the constipating activity and safety of loperamide, diphenoxylate and codeine in normal volunteers.
    Schuermans V; Van Lommel R; Dom J; Brugmans J
    Arzneimittelforschung; 1974 Oct; 24(10):1653-7. PubMed ID: 4611432
    [No Abstract]   [Full Text] [Related]  

  • 17. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
    Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis.
    Langmead L; Feakins RM; Goldthorpe S; Holt H; Tsironi E; De Silva A; Jewell DP; Rampton DS
    Aliment Pharmacol Ther; 2004 Apr; 19(7):739-47. PubMed ID: 15043514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.
    Verne GN; Davis RH; Robinson ME; Gordon JM; Eaker EY; Sninksy CA
    Am J Gastroenterol; 2003 May; 98(5):1112-6. PubMed ID: 12809836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.